Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes

Diabetes Care. 2000 Jun;23(6):733-8. doi: 10.2337/diacare.23.6.733.

Abstract

Objective: To compare the effects of short-term dietary supplementation with tomato juice, vitamin E, and vitamin C on susceptibility of LDL to oxidation and circulating levels of C-reactive protein (C-RP) and cell adhesion molecules in patients with type 2 diabetes.

Research design and methods: There were 57 patients with well-controlled type 2 diabetes aged <75 years treated with placebo for 4 weeks and then randomized to receive tomato juice (500 ml/day), vitamin E (800 U/day), vitamin C (500 mg/day), or continued placebo treatment for 4 weeks. Susceptibility of LDL to oxidation (lag time) and plasma concentrations of lycopene, vitamin E, vitamin C, C-RP, vascular cell adhesion molecule 1, and intercellular adhesion molecule 1 were measured at the beginning of the study, after the placebo phase, and at the end of the study.

Results: Plasma lycopene levels increased nearly 3-fold (P = 0.001), and the lag time in isolated LDL oxidation by copper ions increased by 42% (P = 0.001) in patients during supplementation with tomato juice. The magnitude of this increase in lag time was comparable with the corresponding increase during supplementation with vitamin E (54%). Plasma C-RP levels decreased significantly (-49%, P = 0.004) in patients who received vitamin E. Circulating levels of cell adhesion molecules and plasma glucose did not change significantly during the study.

Conclusions: This study indicates that consumption of commercial tomato juice increases plasma lycopene levels and the intrinsic resistance of LDL to oxidation almost as effectively as supplementation with a high dose of vitamin E, which also decreases plasma levels of C-RP, a risk factor for myocardial infarction, in patients with diabetes. These findings may be relevant to strategies aimed at reducing risk of myocardial infarction in patients with diabetes.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apolipoprotein A-I / blood
  • Apolipoproteins B / blood
  • Ascorbic Acid / pharmacology*
  • Beverages
  • Blood Pressure
  • C-Reactive Protein / analysis*
  • Carotenoids / blood
  • Cell Adhesion Molecules / blood*
  • Cholesterol, HDL / blood
  • Diabetes Mellitus, Type 2 / blood*
  • Dietary Supplements*
  • Female
  • Humans
  • Intercellular Adhesion Molecule-1 / blood
  • Lipoproteins, LDL / blood*
  • Lipoproteins, LDL / drug effects
  • Lycopene
  • Male
  • Middle Aged
  • Placebos
  • Solanum lycopersicum*
  • Triglycerides / blood
  • Vascular Cell Adhesion Molecule-1 / blood
  • Vitamin E / pharmacology*

Substances

  • Apolipoprotein A-I
  • Apolipoproteins B
  • Cell Adhesion Molecules
  • Cholesterol, HDL
  • Lipoproteins, LDL
  • Placebos
  • Triglycerides
  • Vascular Cell Adhesion Molecule-1
  • oxidized low density lipoprotein
  • Intercellular Adhesion Molecule-1
  • Vitamin E
  • Carotenoids
  • C-Reactive Protein
  • Ascorbic Acid
  • Lycopene